JP2024544623A5 - - Google Patents
Info
- Publication number
- JP2024544623A5 JP2024544623A5 JP2024531664A JP2024531664A JP2024544623A5 JP 2024544623 A5 JP2024544623 A5 JP 2024544623A5 JP 2024531664 A JP2024531664 A JP 2024531664A JP 2024531664 A JP2024531664 A JP 2024531664A JP 2024544623 A5 JP2024544623 A5 JP 2024544623A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- cell
- srrna
- composition
- pci
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163283660P | 2021-11-29 | 2021-11-29 | |
| US63/283,660 | 2021-11-29 | ||
| PCT/US2022/080515 WO2023097317A1 (en) | 2021-11-29 | 2022-11-28 | Methods of generating self-replicating rna molecules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544623A JP2024544623A (ja) | 2024-12-03 |
| JP2024544623A5 true JP2024544623A5 (https=) | 2025-12-08 |
Family
ID=86540396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024531664A Pending JP2024544623A (ja) | 2021-11-29 | 2022-11-28 | 自己複製ｒｎａ分子の生成方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250019745A1 (https=) |
| EP (1) | EP4441075A4 (https=) |
| JP (1) | JP2024544623A (https=) |
| KR (1) | KR20240136943A (https=) |
| CN (1) | CN118541381A (https=) |
| AU (1) | AU2022396547A1 (https=) |
| CA (1) | CA3239025A1 (https=) |
| IL (1) | IL313199A (https=) |
| WO (1) | WO2023097317A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120555511A (zh) * | 2025-05-29 | 2025-08-29 | 杭州依思康医药科技有限公司 | 一种mRNA转录骨架载体及其在制备自扩增型mRNA疫苗中的应用 |
| CN120924733B (zh) * | 2025-10-14 | 2026-03-10 | 南京农业大学三亚研究院 | 一种用于同时检测chikv、bfv、rrv的三重荧光定量pcr检测试剂盒 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3061826A1 (en) * | 2015-02-27 | 2016-08-31 | Novartis AG | Flavivirus replicons |
| US12083174B2 (en) * | 2018-08-17 | 2024-09-10 | Glaxosmithkline Biologicals Sa | Immunogenic compositions and uses thereof |
| US20210363543A1 (en) * | 2018-10-30 | 2021-11-25 | Nantbio, Inc. | Self Replicating RNA System |
| US20220054611A1 (en) * | 2018-12-17 | 2022-02-24 | Immune Design Corp. | Pathogen-associated molecular pattern molecules and rna immunogenic compositions and methods of using the compositions for treating cancer |
| KR20230172527A (ko) * | 2021-04-21 | 2023-12-22 | 레플리케이트 바이오사이언스, 인크. | 범용 클로닝 어댑터를 함유하는 알파바이러스 벡터 |
-
2022
- 2022-11-28 CA CA3239025A patent/CA3239025A1/en active Pending
- 2022-11-28 EP EP22899579.1A patent/EP4441075A4/en active Pending
- 2022-11-28 IL IL313199A patent/IL313199A/en unknown
- 2022-11-28 AU AU2022396547A patent/AU2022396547A1/en active Pending
- 2022-11-28 US US18/714,038 patent/US20250019745A1/en active Pending
- 2022-11-28 CN CN202280089068.4A patent/CN118541381A/zh active Pending
- 2022-11-28 JP JP2024531664A patent/JP2024544623A/ja active Pending
- 2022-11-28 KR KR1020247021340A patent/KR20240136943A/ko active Pending
- 2022-11-28 WO PCT/US2022/080515 patent/WO2023097317A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024544623A5 (https=) | ||
| EP2042193A1 (en) | RNA Vaccines | |
| US20190216898A1 (en) | Interleukin Combination and Use Thereof | |
| IL321714A (en) | Novel artificial nucleic acid molecules | |
| CN109328233A (zh) | 反式复制rna | |
| JP2023541108A5 (https=) | ||
| JPH09511143A (ja) | アルファーウイルスｃＤＮＡベクター | |
| JPH06508039A (ja) | 抗腫瘍治療のためのサイトカインを発現する組換え型欠損アデノウイルス | |
| CN108841796A (zh) | 重组单纯疱疹病毒及其制备方法和应用 | |
| JP2002500017A5 (https=) | ||
| Colmenero et al. | Immunotherapy with recombinant SFV‐replicons expressing the P815A tumor antigen or IL‐12 induces tumor regression | |
| US6844188B1 (en) | Methods and modified cells for the treatment of cancer | |
| AU3744099A (en) | Methods and modified cells for the treatment of cancer | |
| CN118846113A (zh) | 一种偶联CD5抗体的mRNA脂质纳米粒及其应用 | |
| Roche et al. | Semliki Forest virus‐mediated gene therapy of the RG2 rat glioma | |
| US20260109975A1 (en) | Self-replicating rna and use thereof | |
| TW202206448A (zh) | 細胞介素免疫療法 | |
| JP2024535729A5 (https=) | ||
| JP2024544623A (ja) | 自己複製ｒｎａ分子の生成方法 | |
| DeLong et al. | Toward RNA nanoparticle vaccines: synergizing RNA and inorganic nanoparticles to achieve immunopotentiation | |
| CN102038958A (zh) | 一种纳米粒子组合物及其应用 | |
| Sivanandham et al. | Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model | |
| CN117883410A (zh) | 包封有mRNA及Acod1基因si-RNA的脂质体纳米颗粒及其应用 | |
| CN101120086A (zh) | 用于肿瘤治疗的黄病毒复制子结构 | |
| CN116837029A (zh) | 表达il-7和gm-csf的sinv载体及其在制备抗肿瘤药物中的应用 |